0001701541-19-000004.txt : 20190716
0001701541-19-000004.hdr.sgml : 20190716
20190716125508
ACCESSION NUMBER: 0001701541-19-000004
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20190716
DATE AS OF CHANGE: 20190716
EFFECTIVENESS DATE: 20190716
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Black Diamond Therapeutics, Inc.
CENTRAL INDEX KEY: 0001701541
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-329523
FILM NUMBER: 19956695
BUSINESS ADDRESS:
STREET 1: 139 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-417-5868
MAIL ADDRESS:
STREET 1: 139 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Aset Therapeutics, Inc.
DATE OF NAME CHANGE: 20170321
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001701541
Black Diamond Therapeutics, Inc.
139 MAIN STREET
CAMBRIDGE
MA
MASSACHUSETTS
02142
617-417-5868
DELAWARE
Aset Therapeutics, Inc.
Corporation
true
2016
David
M.
Epstein
139 Main Street
Cambridge
MA
MASSACHUSETTS
02142
Executive Officer
Director
Elizabeth
Buck
139 Main Street
Cambridge
MA
MASSACHUSETTS
02142
Executive Officer
Fang
Ni
139 Main Street
Cambridge
MA
MASSACHUSETTS
02142
Executive Officer
Ali
Behbahani
139 Main Street
Cambridge
MA
MASSACHUSETTS
02142
Director
Rajeev
Shah
139 Main Street
Cambridge
MA
MASSACHUSETTS
02142
Director
Alexander
Mayweg
139 Main Street
Cambridge
MA
MASSACHUSETTS
02142
Director
Bradley
Bolzon
139 Main Street
Cambridge
MA
MASSACHUSETTS
02142
Director
Garry
E.
Menzel
139 Main Street
Cambridge
MA
MASSACHUSETTS
02142
Director
Brent
Hatzis-Schoch
139 Main Street
Cambridge
MA
MASSACHUSETTS
02142
Executive Officer
Biotechnology
Decline to Disclose
- 06b
true
0001701541-19-000001
2018-12-21
false
true
false
0
87224867
44236469
42988398
false
16
0
0
0
false
Black Diamond Therapeutics, Inc.
/s/ David M. Epstein
David M. Epstein
President and Chief Executive Officer
2019-07-16